Lantheus diversifies supply of radioisotope
Other headlines:Brit readies PACS launch for SIIM
Lantheus diversifies supply of radioisotope
Lantheus Medical has signed NTP Radioisotopes as a supplier of molybdenum-99, which generates technetium, a key component of Lantheus' SPECT nuclear cardiology agent Cardiolite. The agreement provides a second source of the radioisotope generator, which Lantheus had previously obtained primarily from the aging Canadian nuclear reactor at Chalk River (New moly-99 shortage threatens following Chalk River reactor shutdown). NTP Radioisotopes, a subsidiary of the South African Nuclear Energy Corporation, will ship the isotope at regular intervals. To further bolster the new agreement, NTP has partnered with Belgian radiochemical producer IRE to cosupply the isotope to Lantheus.
Brit readies PACS launch for SIIM
PACS/IT vendor Brit Systems will launch its next-generation, browser-based PACS, Roentgen Works, at the Society for Imaging Informatics in Medicine conference next month in Charlotte, NC. The company will also release SpeechWorks, a voice recognition and real-time structured reporting solution that can be integrated with the BRIT Vision workstation, and UrgentWorks, a browser-based critical results reporting and discordance tool.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
